K-numberK242604
Device nameHelios+ UV-C System
ApplicantPreventamed Technologies, Inc. Dba Surfacide Manufacturing
Product codeQXJ
Device classClass II
Decision dateMay 27, 2025
DecisionSubstantially Equivalent
Regulation880.6510
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Helios+ UV-C System is a portable, germicidal ultraviolet light device that emits 253.7 nm wavelength UV-C light to reduce microbial contamination on non-porous, non-critical medical device surfaces in unoccupied rooms. It is used in operating rooms, hospital rooms, and clinical settings as an adjunct to manual cleaning and disinfection, and is available over-the-counter (OTC).

Technological characteristics

Helios+ uses continuous 253.7 nm UV-C light and can be deployed in multiple configurations with 1-3 emitters, whereas the predicate uses pulsed broad-spectrum UV light with a single emitter. Helios+ is remotely operated via a Bluetooth-connected control tablet with up to 3 wireless safety sensors, while the predicate uses an on-device touchpad and a single tethered motion detection cone. Both achieve identical 2-log microbial reduction performance on target organisms.

Test standards cited

IEC 62471 (Photobiological Safety of Lamps and Lamp Systems), IEC 61010-1 (electrical safety), IEC 61326-1 (electromagnetic compatibility), ISO 4582, ASTM D256-10, ASTM A370-22 (materials durability), and 21 CFR 801.415 (ozone limits). FDA guidance on device software and cybersecurity was also applied.

Substantial equivalence argument

Both devices are whole-room microbial reduction systems with identical intended use, regulatory classification, and demonstrated 2-log microbial reduction performance on the same target organisms. Although Helios+ differs in operational controls (tablet vs. touchpad), emitter configuration (1-3 vs. single), wavelength delivery method (continuous vs. pulsed), and safety sensor design (wireless vs. tethered), these technological differences do not raise different safety or effectiveness questions because the non-clinical testing shows equivalent or superior performance, proper safety controls are maintained, and the fundamental mechanism and microbial reduction outcomes remain substantially the same.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →